Related by context. Frequent words. (Click for all words.) 78 Advanced Prostate Cancer 76 Chronic Hepatitis C 75 Elderly Patients 75 Bladder Cancer 75 Metastatic Melanoma 74 Well Tolerated 73 Heart Failure Patients 73 Prostate Cancer Patients 73 Metastatic Colorectal Cancer 73 Metastatic 73 Drug Resistant 72 Clinical Trial Results 72 Combination Therapy 71 Breast Cancer Patients 71 Postmenopausal Women 71 Chronic Lymphocytic Leukemia 71 Carcinoma 71 Cardiovascular Events 71 Glioma 71 Drug Candidate 71 Epratuzumab 71 Patients Treated 71 Diabetic Patients 71 Monotherapy 70 Metastatic Breast Cancer 70 Overactive Bladder 70 Low Dose 70 Breast Cancer Treatment 69 Prostate Cancer Treatment 69 Cancer Cells 69 Esophageal Cancer 69 Ischemic 69 Meta Analysis 69 Dialysis Patients 69 Acute Myocardial Infarction 69 Pulmonary Arterial Hypertension 69 Preclinical Data 69 Benign Prostatic Hyperplasia 69 Allergic Rhinitis 69 Autoimmune Diseases 69 Randomized Controlled Trial 69 Phase III Clinical Trial 69 Insulin Resistance 69 Thyroid Cancer 68 Hormone Therapy 68 Inhibits 68 Gum Disease 68 Bortezomib 68 Treatable 68 Urinary Incontinence 68 Monoclonal Antibody 68 Chronic Heart Failure 68 Hepatitis C Virus 68 Phase III Trial 68 Targeted Therapy 68 Atopic Dermatitis 68 Brain Tumors 68 Completes Enrollment 68 Reduces Risk 68 Increased Risk 68 Blood Vessels 67 Study Demonstrates 67 Smallpox Vaccine 67 Esophageal 67 Holds Promise 67 Alemtuzumab 67 Regimens 67 Pivotal Phase 67 Monoclonal Antibodies 67 Cancer Treatments 67 Patient Enrollment 67 Early Diagnosis 67 Lenalidomide 67 Scientists Identify 66 Significantly Reduces 66 Increases Risk 66 Stem Cell Transplant 66 Capecitabine 66 Asymptomatic 66 Small Molecule 66 Bevacizumab 66 Voreloxin 66 Induces 66 Breast Cancer Risk 66 Blood Flow 66 Embryonic Stem Cells 66 FDA Clears 66 Gliomas 66 Presents Positive 65 Systematic Review 65 Cancer Diagnosis 65 Solid Tumors 65 Erlotinib 65 Blood Clots 65 Pivotal Trial 65 Reduce Risk 65 Virtual Colonoscopy 65 Pivotal Phase III 65 Kidney Stones 65 Trastuzumab 65 Tolerability